SCHEMBL2505087

SCHEMBL2505087

CCCCN1Cc2cc(Cc3cncc(-c4ccccc4)c3)ccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
PRF1 P14222 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
IDH1 O75874 1/20 0.37
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36
EGFR P00533 1/20 0.36
PDE10A Q9Y233 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506138 0.86 GRM5 (0.46) GRM5CYP11B1CYP11B2PRF1KDM4E
SCHEMBL2506687 0.84 GRM5 (0.40) GRM5CYP11B2PRF1KDM4EALDH1A1
SCHEMBL2508431 0.81 GRM5 (0.41) GRM5CYP11B2PRF1KDM4EALDH1A1
SCHEMBL2508327 0.81 HDAC6 (0.44) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL2506683 0.80 GRM5 (0.41) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL2505706 0.73 HDAC6 (0.42) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL2503427 0.71 HDAC6 (0.43) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL2507478 0.71 ITGB3 (0.44) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL2514237 0.71 GRM5 (0.40) GRM5PRF1KDM4EALDH1A1LMNA
SCHEMBL25612013 0.70 DHPS (0.55) GRM5CYP11B1CYP11B2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314120-B2 Small molecule potentiators of metabotropic glutamate receptors ABBOTT GMBH & CO. KG (DE) 2012-11-20 US claimed
US-8314120-B2 Small molecule potentiators of metabotropic glutamate receptors ABBOTT GMBH & CO. KG (DE) 2012-11-20 US disclosed
US-20110245247-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245247-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRIN2C, GRM3, GRM2 GRM5 18/4885CYP11B1 381/4885CYP11B2 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.